A Clinical Trial to Evaluate the Reversibility of Abacavir/Lamivudine/Dolutegravir CNS-Related Neurotoxicity After Switching to Tenofovir/Alafenamide/Emtricitabine/Darunavir/Cobicistat (TAF/FTC/DRV/c)
- Conditions
- HIV Infections
- Interventions
- Drug: Symtuza® (TAF/FTC/DRV/c)Drug: ABC/3TC/DTG + Symtuza® (TAF/FTC/DRV/c)
- First Posted Date
- 2018-09-26
- Last Posted Date
- 2022-06-22
- Lead Sponsor
- Fundacion SEIMC-GESIDA
- Target Recruit Count
- 78
- Registration Number
- NCT03685500
- Locations
- 🇪🇸
H. Univ. Príncipe de Asturias, Madrid, Spain
🇪🇸Hospital Universitario La Paz, Madrid, Spain
🇪🇸Hospital Puerta de Hierro, Majadahonda, Madrid, Spain
A Clinical Trial to Evaluate the Immunogenicity of the Nonavalent Vaccine Against Human Papillomavirus in Men Infected by HIV Who Have Sex With Men. GESIDA 10017
- Conditions
- HIV Infections
- Interventions
- Biological: HPV9v
- First Posted Date
- 2018-08-13
- Last Posted Date
- 2023-08-25
- Lead Sponsor
- Fundacion SEIMC-GESIDA
- Target Recruit Count
- 158
- Registration Number
- NCT03626467
- Locations
- 🇪🇸
Hospital Ramón y Cajal, Madrid, Spain
🇪🇸Hospital Fundación Jimenez Díaz, Madrid, Spain
🇪🇸Hospital La Paz, Madrid, Spain
Spanish Cohort of Patients With HIV Infection Older Than 50 Years for the Study of Fragility and Physical Function
- Conditions
- HIV InfectionsFrail Older Adults
- First Posted Date
- 2018-06-15
- Last Posted Date
- 2023-08-25
- Lead Sponsor
- Fundacion SEIMC-GESIDA
- Target Recruit Count
- 802
- Registration Number
- NCT03558438
Switching Strategy With Raltegravir + ABC / 3TC in Controlled HIV-1 Infection
- Conditions
- HIV Infections
- First Posted Date
- 2017-05-17
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Fundacion SEIMC-GESIDA
- Target Recruit Count
- 467
- Registration Number
- NCT03158077
- Locations
- 🇪🇸
Hospital de Alicante, Alicante, Alcante, Spain
🇪🇸Hopital Severo Ochoa, Madrid, Spain
🇪🇸Hospital de Mataró, Mataró, Barcelona, Spain
A Clinical Trial of 16 Weeks of Duration to Evaluate Retreatment With Elbasvir/Grazoprevir Plus Sofosbuvir and Ribavirin in Patients With Chronic Hepatitis C Genotypes 1,4 Who Have Failed to Treat With a Regime Based on an Inhibitor of the NS5A
- First Posted Date
- 2017-04-07
- Last Posted Date
- 2018-06-08
- Lead Sponsor
- Fundacion SEIMC-GESIDA
- Registration Number
- NCT03105349
- Locations
- 🇪🇸
Hospital Infanta Leonor, Madrid, Spain
🇪🇸Hospital Univ. Gregorio Marañon, Madrid, Spain
🇪🇸Hospital Univ. La Paz, Madrid, Spain
A Phase IV, Open-label, Randomised, Pilot Clinical Trial Designed to Evaluate the Potential Neurotoxicity of Dolutegravir/Lamivudine/Abacavir in Neurosymptomatic HIV Patients and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide. DREAM Study
- Conditions
- HIV Infections
- Interventions
- Drug: DTG/3TC/ABC + ELV/COBI/FTC/TAFDrug: ELV/COBI/FTC/TAF
- First Posted Date
- 2017-03-01
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Fundacion SEIMC-GESIDA
- Target Recruit Count
- 39
- Registration Number
- NCT03067285
- Locations
- 🇪🇸
Hospital Puerta de Hierro, Majadahonda, Madrid, Spain
🇪🇸Hospital Fundación Jimenez Díaz, Madrid, Spain
🇪🇸Hospital Ramón y Cajal, Madrid, Spain
Study of the Effectiveness and Safety of Darunavir/Cobicistat (DRV/c) Containing Regimens in Routine Clinical Practice
- Conditions
- HIV Infections
- First Posted Date
- 2017-02-03
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Fundacion SEIMC-GESIDA
- Target Recruit Count
- 762
- Registration Number
- NCT03042390
- Locations
- 🇪🇸
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
🇪🇸Hospital del Mar, Barcelona, Spain
🇪🇸Hospital del Vall d'Hebron, Barcelona, Spain
Study to Evaluate Darunavir/Ritonavir + Lamivudine Versus Continuing With Darunavir/Ritonavir + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected Subject
- Conditions
- HIV Infection
- Interventions
- First Posted Date
- 2014-06-10
- Last Posted Date
- 2017-02-14
- Lead Sponsor
- Fundacion SEIMC-GESIDA
- Target Recruit Count
- 249
- Registration Number
- NCT02159599
- Locations
- 🇪🇸
Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain
🇪🇸Hospital General Universitario de Alicante, Alicante, Spain
🇪🇸Hospital Universitario Germans Trias i Pujol, Badalona, Spain
Retrospective Study to Determine the Incidence of Bone Fractures in HIV-infected Patients in Spain
- Conditions
- HIV
- First Posted Date
- 2014-01-27
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Fundacion SEIMC-GESIDA
- Target Recruit Count
- 250
- Registration Number
- NCT02045537
- Locations
- 🇪🇸
H. de Mataró, Mataró, Barcelona, Spain
🇪🇸H. de Elche, Elche, Alicante, Spain
🇪🇸H. Marina Baixa, Villajoyosa, Alicante, Spain
Observational, Retrospective, Multicenter Study to Describe the Reasons for the Change of the Regimen of Antiretroviral Therapy in HIV Patients
- Conditions
- HIV
- First Posted Date
- 2014-01-20
- Last Posted Date
- 2016-06-29
- Lead Sponsor
- Fundacion SEIMC-GESIDA
- Target Recruit Count
- 250
- Registration Number
- NCT02039921
- Locations
- 🇪🇸
Hospital San Cecilio, Granada, Spain
🇪🇸Hospital Vall D'Hebron, Barcelona, Spain
🇪🇸Hospital Gregorio Marañón, Madrid, Spain